Back to top
more

Meridian Bioscience Inc. (VIVO)

(Delayed Data from NSDQ)

$11.51 USD

11.51
1,168,817

-0.48 (-4.00%)

Updated May 3, 2019 04:00 PM ET

After-Market: $11.50 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

New Strong Buy Stocks for February 10th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.

Cardiovascular System's (CSII) OAS Cures 1st Patient in Europe

Cardiovascular System's (CSII) Diamondback 360 Coronary OAS provides physicians in Europe with an effective treatment option for difficult-to-treat patient population.

Boston Scientific (BSX) Hurt by Product Recall, Conversion

Barring MedSurg, organic revenues at each of Boston Scientific (BSX) core segments and geographies are down in Q4 but the magnitude of this decline is lower than Q3.

Is Meridian Bioscience (VIVO) Stock Outpacing Its Medical Peers This Year?

Is (VIVO) Outperforming Other Medical Stocks This Year?

Meridian Bioscience (VIVO) Q1 Earnings and Revenues Surpass Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 54.76% and 1.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Meridian (VIVO) Might Surprise This Earnings Season

Meridian (VIVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Kevin Cook headshot

Biotech Bonanza: COVID Launches Science at Warp Speed

From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.

Cigna (CI) to Report Q4 Earnings: What's in the Offing?

Cigna's (CI) fourth-quarter results are likely to reflect strong performance across the business portfolio and lower SG&A costs, partly offset by continued COVID-19 related expenses.

What's in Store for Meridian Bioscience's (VIVO) Q1 Earnings?

Meridian Bioscience's (VIVO) fiscal first-quarter results are likely to reflect strong performance by Life Science business line.

Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know

In the latest trading session, Meridian Bioscience (VIVO) closed at $22.10, marking a +1.33% move from the previous day.

Urmimala Biswas headshot

3 MedTech Stocks Likely to Top Estimates This Earnings Season

Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.

ResMed (RMD) Q2 Earnings Surpass Estimates, Margins Rise

ResMed (RMD) reported second-quarter fiscal 2021 revenues of $800 million, up 9% from a year ago.

Smith+Nephew's (SNN) PICO sNPWT Study Outcome Encouraging

Smith+Nephew's (SNN) PICO Single Use Negative Pressure Wound Therapy System (sNPWT) considerably reduces surgical site infections complications and provides better patient outcome.

Abbott (ABT) Q4 Earnings Top, Diagnostic Test Sales Solid

Within Diabetes Care, Abbott (ABT) reports strong sales banking on growing demand for sensor-based continuous glucose monitoring system, FreeStyle Libre.

Boston Scientific (BSX) Enhances Core Business With Buyout

Boston Scientific's (BSX) acquisition of Preventice solutions enables the former to expand rhythm management diagnostics portfolio and abilities.

Meridian Bioscience (VIVO) Stock Sinks As Market Gains: What You Should Know

Meridian Bioscience (VIVO) closed at $22.60 in the latest trading session, marking a -0.88% move from the prior day.

Integra (IART) Acquires Acell, Focuses on Regenerative Space

The acquisition is expected to remain accretive to Integra's (IART) revenue growth and adjusted gross margins.

Why the Earnings Surprise Streak Could Continue for Meridian Bioscience (VIVO)

Meridian Bioscience (VIVO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays

Globus Medical's (GMED) recent product launches are seeing tremendous uptake.

Insulet (PODD) Omnipod DASH Reaches Canada, Global Hold Widens

Insulet's (PODD) Omnipod DASH system provides 72 hours of continuous insulin therapy, simplifying lives with no more daily injection.

PerkinElmer (PKI) Receives FDA EUA for Asymptomatic Testing

PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.

Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know

Meridian Bioscience (VIVO) closed at $22.13 in the latest trading session, marking a +1.33% move from the prior day.

Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Owens & Minor and Lakeland Industries

Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Owens & Minor and Lakeland Industries

Meridian Bioscience, PayPal, Microsoft and JPMorgan highlighted as Zacks Bull and Bear of the Day

Meridian Bioscience, PayPal, Microsoft and JPMorgan highlighted as Zacks Bull and Bear of the Day

Nilanjan Banerjee headshot

Buy These 5 Low-Beta Stocks to Combat the Choppy Market

Low-beta stocks may be able to help sail through the choppy market conditions.